货号:A1174776 同义名:
Immunoglobulin G2; Ranmark
Denosumab是一种人源化IgG2单克隆抗体,通过与RANKL结合来阻止其与RANK受体结合。Denosumab具有用于骨质疏松症和骨转移癌研究的潜力。
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
QNZ |
++++
NF-κB, IC50: 11 nM | 99%+ | |||||||||||||||||
Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
Sodium Salicylate | ✔ | 95% | |||||||||||||||||
Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
JSH-23 |
+
NF-κB, IC50: 7.1 μM | 98% | |||||||||||||||||
Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
Andrographolide | ✔ | 98+% | |||||||||||||||||
Curcumin | ✔ | Nrf2,HDAC | 98% | ||||||||||||||||
SC75741 |
+++
NF-κB, EC50: 200 nM | 99%+ | |||||||||||||||||
CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM | p53 | 99%+ | ||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Product Name: Denosumab Cross-reactivity: Human,Cynomolgus Organism:Human Target name: TNFSF11 / RANKL / CD254 Recommended Dilution Buffer: Sterile PBS or 0.9% saline for reconstitution/dilution. It is recommended to use the reconstituted/diluted product within one month. Formulation: 100 mM Pro-Ac,20 mM Arg,pH5.0 Endotoxin: < 0.001EU/μg, determined by LAL method. Purity: >95%. Determined by SDS-PAGE Purification: Purified, Protein A, affinity column Storage: -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles. Isotype: IgG1-Kappa |
CAS号 | 615258-40-7 |
分子量 | 145.16 kDa |
SMILES Code | NONE |
MDL No. | N/A |
别名 | Immunoglobulin G2; Ranmark |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:24个月 |